Combination Immunotherapy in Prostate Cancer

Combination Immunotherapy in Prostate Cancer

During the last decade, there has been significant progress in the field of prostate cancer therapeutic treatments based on androgen receptor-axis-targeted therapies, which resulted in improved clinical outcomes [...].

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers 2022-12, Vol.14 (24), p.6040
Hauptverfasser: Baxevanis, Constantin N, Goulielmaki, Maria, Gritzapis, Angelos D, Fortis, Sotirios P
Format: Artikel
Sprache:eng
Schlagworte:
Androgens
Apoptosis
Biomarkers
Cancer therapies
Care and treatment
Chemotherapy
Clinical outcomes
Conflicts of interest
Immunotherapy
Lymphocytes
Metastasis
Methods
Prostate cancer
Vaccines
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:During the last decade, there has been significant progress in the field of prostate cancer therapeutic treatments based on androgen receptor-axis-targeted therapies, which resulted in improved clinical outcomes [...].
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers14246040